nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CYP3A5—Sorafenib—liver cancer	0.138	0.28	CbGbCtD
Oxybutynin—CYP2C8—Sorafenib—liver cancer	0.133	0.269	CbGbCtD
Oxybutynin—CYP2D6—Sorafenib—liver cancer	0.0849	0.172	CbGbCtD
Oxybutynin—CYP3A4—Sorafenib—liver cancer	0.054	0.109	CbGbCtD
Oxybutynin—CYP2D6—Doxorubicin—liver cancer	0.0515	0.104	CbGbCtD
Oxybutynin—CYP3A4—Doxorubicin—liver cancer	0.0327	0.0662	CbGbCtD
Oxybutynin—Cystitis noninfective—Doxorubicin—liver cancer	0.00134	0.00351	CcSEcCtD
Oxybutynin—Melaena—Doxorubicin—liver cancer	0.00134	0.00351	CcSEcCtD
Oxybutynin—Salivary hypersecretion—Doxorubicin—liver cancer	0.00134	0.00349	CcSEcCtD
Oxybutynin—Cystitis—Doxorubicin—liver cancer	0.00133	0.00347	CcSEcCtD
Oxybutynin—Colitis—Doxorubicin—liver cancer	0.00132	0.00345	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00131	0.00342	CcSEcCtD
Oxybutynin—Fluid retention—Doxorubicin—liver cancer	0.00131	0.00341	CcSEcCtD
Oxybutynin—Hypertonia—Epirubicin—liver cancer	0.0013	0.00341	CcSEcCtD
Oxybutynin—Abnormal vision—Epirubicin—liver cancer	0.0013	0.00339	CcSEcCtD
Oxybutynin—Mental disability—Epirubicin—liver cancer	0.00129	0.00337	CcSEcCtD
Oxybutynin—Dry eye—Doxorubicin—liver cancer	0.00127	0.00332	CcSEcCtD
Oxybutynin—Dyspepsia—Sorafenib—liver cancer	0.00126	0.0033	CcSEcCtD
Oxybutynin—Oesophagitis—Doxorubicin—liver cancer	0.00126	0.00329	CcSEcCtD
Oxybutynin—Decreased appetite—Sorafenib—liver cancer	0.00125	0.00326	CcSEcCtD
Oxybutynin—Mouth ulceration—Doxorubicin—liver cancer	0.00124	0.00325	CcSEcCtD
Oxybutynin—Bladder pain—Doxorubicin—liver cancer	0.00124	0.00325	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Sorafenib—liver cancer	0.00124	0.00324	CcSEcCtD
Oxybutynin—Fatigue—Sorafenib—liver cancer	0.00124	0.00323	CcSEcCtD
Oxybutynin—Pain—Sorafenib—liver cancer	0.00123	0.00321	CcSEcCtD
Oxybutynin—Constipation—Sorafenib—liver cancer	0.00123	0.00321	CcSEcCtD
Oxybutynin—Hypertonia—Doxorubicin—liver cancer	0.00121	0.00315	CcSEcCtD
Oxybutynin—Abnormal vision—Doxorubicin—liver cancer	0.0012	0.00314	CcSEcCtD
Oxybutynin—Eye pain—Epirubicin—liver cancer	0.0012	0.00312	CcSEcCtD
Oxybutynin—Mental disability—Doxorubicin—liver cancer	0.00119	0.00312	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Sorafenib—liver cancer	0.00117	0.00307	CcSEcCtD
Oxybutynin—Hot flush—Epirubicin—liver cancer	0.00115	0.00302	CcSEcCtD
Oxybutynin—Increased appetite—Epirubicin—liver cancer	0.00115	0.003	CcSEcCtD
Oxybutynin—Menopausal symptoms—Epirubicin—liver cancer	0.00114	0.00299	CcSEcCtD
Oxybutynin—Urticaria—Sorafenib—liver cancer	0.00114	0.00298	CcSEcCtD
Oxybutynin—Abdominal pain—Sorafenib—liver cancer	0.00114	0.00297	CcSEcCtD
Oxybutynin—Dermatitis bullous—Epirubicin—liver cancer	0.00113	0.00295	CcSEcCtD
Oxybutynin—Eye pain—Doxorubicin—liver cancer	0.00111	0.00289	CcSEcCtD
Oxybutynin—Osteoarthritis—Epirubicin—liver cancer	0.00108	0.00282	CcSEcCtD
Oxybutynin—Pain in extremity—Epirubicin—liver cancer	0.00108	0.00282	CcSEcCtD
Oxybutynin—Hot flush—Doxorubicin—liver cancer	0.00107	0.00279	CcSEcCtD
Oxybutynin—Increased appetite—Doxorubicin—liver cancer	0.00106	0.00278	CcSEcCtD
Oxybutynin—Affect lability—Epirubicin—liver cancer	0.00106	0.00278	CcSEcCtD
Oxybutynin—Migraine—Epirubicin—liver cancer	0.00106	0.00278	CcSEcCtD
Oxybutynin—Menopausal symptoms—Doxorubicin—liver cancer	0.00106	0.00277	CcSEcCtD
Oxybutynin—Hypersensitivity—Sorafenib—liver cancer	0.00106	0.00276	CcSEcCtD
Oxybutynin—Dermatitis bullous—Doxorubicin—liver cancer	0.00105	0.00273	CcSEcCtD
Oxybutynin—Face oedema—Epirubicin—liver cancer	0.00104	0.00272	CcSEcCtD
Oxybutynin—Asthenia—Sorafenib—liver cancer	0.00103	0.00269	CcSEcCtD
Oxybutynin—Mood swings—Epirubicin—liver cancer	0.00102	0.00267	CcSEcCtD
Oxybutynin—Pruritus—Sorafenib—liver cancer	0.00102	0.00265	CcSEcCtD
Oxybutynin—Blood creatinine increased—Epirubicin—liver cancer	0.00101	0.00264	CcSEcCtD
Oxybutynin—Osteoarthritis—Doxorubicin—liver cancer	0.000999	0.00261	CcSEcCtD
Oxybutynin—Pain in extremity—Doxorubicin—liver cancer	0.000999	0.00261	CcSEcCtD
Oxybutynin—Liver function test abnormal—Epirubicin—liver cancer	0.000997	0.0026	CcSEcCtD
Oxybutynin—Dry skin—Epirubicin—liver cancer	0.00099	0.00259	CcSEcCtD
Oxybutynin—Abdominal pain upper—Epirubicin—liver cancer	0.000986	0.00258	CcSEcCtD
Oxybutynin—Affect lability—Doxorubicin—liver cancer	0.000983	0.00257	CcSEcCtD
Oxybutynin—Migraine—Doxorubicin—liver cancer	0.000983	0.00257	CcSEcCtD
Oxybutynin—Diarrhoea—Sorafenib—liver cancer	0.000982	0.00257	CcSEcCtD
Oxybutynin—Breast disorder—Epirubicin—liver cancer	0.000976	0.00255	CcSEcCtD
Oxybutynin—Nasopharyngitis—Epirubicin—liver cancer	0.000965	0.00252	CcSEcCtD
Oxybutynin—Face oedema—Doxorubicin—liver cancer	0.000964	0.00252	CcSEcCtD
Oxybutynin—Dizziness—Sorafenib—liver cancer	0.000949	0.00248	CcSEcCtD
Oxybutynin—Mood swings—Doxorubicin—liver cancer	0.000946	0.00247	CcSEcCtD
Oxybutynin—Abdominal distension—Epirubicin—liver cancer	0.000939	0.00245	CcSEcCtD
Oxybutynin—Blood creatinine increased—Doxorubicin—liver cancer	0.000936	0.00245	CcSEcCtD
Oxybutynin—Dysphagia—Epirubicin—liver cancer	0.000933	0.00244	CcSEcCtD
Oxybutynin—Influenza—Epirubicin—liver cancer	0.000933	0.00244	CcSEcCtD
Oxybutynin—Asthma—Epirubicin—liver cancer	0.000933	0.00244	CcSEcCtD
Oxybutynin—Liver function test abnormal—Doxorubicin—liver cancer	0.000922	0.00241	CcSEcCtD
Oxybutynin—Dry skin—Doxorubicin—liver cancer	0.000916	0.00239	CcSEcCtD
Oxybutynin—Vomiting—Sorafenib—liver cancer	0.000913	0.00239	CcSEcCtD
Oxybutynin—Abdominal pain upper—Doxorubicin—liver cancer	0.000912	0.00238	CcSEcCtD
Oxybutynin—Rash—Sorafenib—liver cancer	0.000905	0.00237	CcSEcCtD
Oxybutynin—Dermatitis—Sorafenib—liver cancer	0.000904	0.00236	CcSEcCtD
Oxybutynin—Breast disorder—Doxorubicin—liver cancer	0.000903	0.00236	CcSEcCtD
Oxybutynin—Headache—Sorafenib—liver cancer	0.000899	0.00235	CcSEcCtD
Oxybutynin—Bronchitis—Epirubicin—liver cancer	0.000897	0.00234	CcSEcCtD
Oxybutynin—Nasopharyngitis—Doxorubicin—liver cancer	0.000893	0.00233	CcSEcCtD
Oxybutynin—Dysuria—Epirubicin—liver cancer	0.000873	0.00228	CcSEcCtD
Oxybutynin—Abdominal distension—Doxorubicin—liver cancer	0.000869	0.00227	CcSEcCtD
Oxybutynin—Upper respiratory tract infection—Epirubicin—liver cancer	0.000867	0.00227	CcSEcCtD
Oxybutynin—Asthma—Doxorubicin—liver cancer	0.000863	0.00226	CcSEcCtD
Oxybutynin—Dysphagia—Doxorubicin—liver cancer	0.000863	0.00226	CcSEcCtD
Oxybutynin—Influenza—Doxorubicin—liver cancer	0.000863	0.00226	CcSEcCtD
Oxybutynin—Pollakiuria—Epirubicin—liver cancer	0.000862	0.00225	CcSEcCtD
Oxybutynin—Nausea—Sorafenib—liver cancer	0.000853	0.00223	CcSEcCtD
Oxybutynin—Infestation NOS—Epirubicin—liver cancer	0.000832	0.00217	CcSEcCtD
Oxybutynin—Infestation—Epirubicin—liver cancer	0.000832	0.00217	CcSEcCtD
Oxybutynin—Drowsiness—Epirubicin—liver cancer	0.000832	0.00217	CcSEcCtD
Oxybutynin—Bronchitis—Doxorubicin—liver cancer	0.00083	0.00217	CcSEcCtD
Oxybutynin—Stomatitis—Epirubicin—liver cancer	0.000811	0.00212	CcSEcCtD
Oxybutynin—Conjunctivitis—Epirubicin—liver cancer	0.000809	0.00211	CcSEcCtD
Oxybutynin—Urinary tract infection—Epirubicin—liver cancer	0.000809	0.00211	CcSEcCtD
Oxybutynin—Dysuria—Doxorubicin—liver cancer	0.000807	0.00211	CcSEcCtD
Oxybutynin—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000802	0.0021	CcSEcCtD
Oxybutynin—Pollakiuria—Doxorubicin—liver cancer	0.000798	0.00208	CcSEcCtD
Oxybutynin—Haematuria—Epirubicin—liver cancer	0.000793	0.00207	CcSEcCtD
Oxybutynin—Epistaxis—Epirubicin—liver cancer	0.000785	0.00205	CcSEcCtD
Oxybutynin—Sinusitis—Epirubicin—liver cancer	0.000781	0.00204	CcSEcCtD
Oxybutynin—Infestation NOS—Doxorubicin—liver cancer	0.00077	0.00201	CcSEcCtD
Oxybutynin—Drowsiness—Doxorubicin—liver cancer	0.00077	0.00201	CcSEcCtD
Oxybutynin—Infestation—Doxorubicin—liver cancer	0.00077	0.00201	CcSEcCtD
Oxybutynin—Stomatitis—Doxorubicin—liver cancer	0.00075	0.00196	CcSEcCtD
Oxybutynin—Rhinitis—Epirubicin—liver cancer	0.000749	0.00196	CcSEcCtD
Oxybutynin—Urinary tract infection—Doxorubicin—liver cancer	0.000748	0.00196	CcSEcCtD
Oxybutynin—Conjunctivitis—Doxorubicin—liver cancer	0.000748	0.00196	CcSEcCtD
Oxybutynin—Hypoaesthesia—Epirubicin—liver cancer	0.000743	0.00194	CcSEcCtD
Oxybutynin—Pharyngitis—Epirubicin—liver cancer	0.000741	0.00194	CcSEcCtD
Oxybutynin—Urinary tract disorder—Epirubicin—liver cancer	0.000738	0.00193	CcSEcCtD
Oxybutynin—Oedema peripheral—Epirubicin—liver cancer	0.000736	0.00192	CcSEcCtD
Oxybutynin—Haematuria—Doxorubicin—liver cancer	0.000734	0.00192	CcSEcCtD
Oxybutynin—Connective tissue disorder—Epirubicin—liver cancer	0.000734	0.00192	CcSEcCtD
Oxybutynin—Urethral disorder—Epirubicin—liver cancer	0.000732	0.00191	CcSEcCtD
Oxybutynin—Epistaxis—Doxorubicin—liver cancer	0.000726	0.0019	CcSEcCtD
Oxybutynin—Sinusitis—Doxorubicin—liver cancer	0.000722	0.00189	CcSEcCtD
Oxybutynin—Visual impairment—Epirubicin—liver cancer	0.00072	0.00188	CcSEcCtD
Oxybutynin—Eye disorder—Epirubicin—liver cancer	0.000698	0.00182	CcSEcCtD
Oxybutynin—Tinnitus—Epirubicin—liver cancer	0.000696	0.00182	CcSEcCtD
Oxybutynin—Flushing—Epirubicin—liver cancer	0.000693	0.00181	CcSEcCtD
Oxybutynin—Cardiac disorder—Epirubicin—liver cancer	0.000693	0.00181	CcSEcCtD
Oxybutynin—Rhinitis—Doxorubicin—liver cancer	0.000693	0.00181	CcSEcCtD
Oxybutynin—Hypoaesthesia—Doxorubicin—liver cancer	0.000688	0.0018	CcSEcCtD
Oxybutynin—Pharyngitis—Doxorubicin—liver cancer	0.000686	0.00179	CcSEcCtD
Oxybutynin—Urinary tract disorder—Doxorubicin—liver cancer	0.000682	0.00178	CcSEcCtD
Oxybutynin—Oedema peripheral—Doxorubicin—liver cancer	0.000681	0.00178	CcSEcCtD
Oxybutynin—Connective tissue disorder—Doxorubicin—liver cancer	0.000679	0.00177	CcSEcCtD
Oxybutynin—Angiopathy—Epirubicin—liver cancer	0.000678	0.00177	CcSEcCtD
Oxybutynin—Urethral disorder—Doxorubicin—liver cancer	0.000677	0.00177	CcSEcCtD
Oxybutynin—Mediastinal disorder—Epirubicin—liver cancer	0.000673	0.00176	CcSEcCtD
Oxybutynin—Arrhythmia—Epirubicin—liver cancer	0.000667	0.00174	CcSEcCtD
Oxybutynin—Visual impairment—Doxorubicin—liver cancer	0.000666	0.00174	CcSEcCtD
Oxybutynin—Mental disorder—Epirubicin—liver cancer	0.000654	0.00171	CcSEcCtD
Oxybutynin—Erythema—Epirubicin—liver cancer	0.00065	0.0017	CcSEcCtD
Oxybutynin—Malnutrition—Epirubicin—liver cancer	0.00065	0.0017	CcSEcCtD
Oxybutynin—Eye disorder—Doxorubicin—liver cancer	0.000646	0.00169	CcSEcCtD
Oxybutynin—Tinnitus—Doxorubicin—liver cancer	0.000644	0.00168	CcSEcCtD
Oxybutynin—Cardiac disorder—Doxorubicin—liver cancer	0.000641	0.00168	CcSEcCtD
Oxybutynin—Flushing—Doxorubicin—liver cancer	0.000641	0.00168	CcSEcCtD
Oxybutynin—Flatulence—Epirubicin—liver cancer	0.000641	0.00167	CcSEcCtD
Oxybutynin—Tension—Epirubicin—liver cancer	0.000638	0.00167	CcSEcCtD
Oxybutynin—Dysgeusia—Epirubicin—liver cancer	0.000637	0.00166	CcSEcCtD
Oxybutynin—Nervousness—Epirubicin—liver cancer	0.000631	0.00165	CcSEcCtD
Oxybutynin—Back pain—Epirubicin—liver cancer	0.000629	0.00164	CcSEcCtD
Oxybutynin—Angiopathy—Doxorubicin—liver cancer	0.000627	0.00164	CcSEcCtD
Oxybutynin—Mediastinal disorder—Doxorubicin—liver cancer	0.000623	0.00163	CcSEcCtD
Oxybutynin—Arrhythmia—Doxorubicin—liver cancer	0.000617	0.00161	CcSEcCtD
Oxybutynin—Vision blurred—Epirubicin—liver cancer	0.000613	0.0016	CcSEcCtD
Oxybutynin—Mental disorder—Doxorubicin—liver cancer	0.000605	0.00158	CcSEcCtD
Oxybutynin—Ill-defined disorder—Epirubicin—liver cancer	0.000603	0.00158	CcSEcCtD
Oxybutynin—Erythema—Doxorubicin—liver cancer	0.000602	0.00157	CcSEcCtD
Oxybutynin—Malnutrition—Doxorubicin—liver cancer	0.000602	0.00157	CcSEcCtD
Oxybutynin—Agitation—Epirubicin—liver cancer	0.000597	0.00156	CcSEcCtD
Oxybutynin—Flatulence—Doxorubicin—liver cancer	0.000593	0.00155	CcSEcCtD
Oxybutynin—Tension—Doxorubicin—liver cancer	0.00059	0.00154	CcSEcCtD
Oxybutynin—Dysgeusia—Doxorubicin—liver cancer	0.000589	0.00154	CcSEcCtD
Oxybutynin—Malaise—Epirubicin—liver cancer	0.000586	0.00153	CcSEcCtD
Oxybutynin—Nervousness—Doxorubicin—liver cancer	0.000584	0.00153	CcSEcCtD
Oxybutynin—Syncope—Epirubicin—liver cancer	0.000583	0.00152	CcSEcCtD
Oxybutynin—Back pain—Doxorubicin—liver cancer	0.000582	0.00152	CcSEcCtD
Oxybutynin—Palpitations—Epirubicin—liver cancer	0.000575	0.0015	CcSEcCtD
Oxybutynin—Loss of consciousness—Epirubicin—liver cancer	0.000571	0.00149	CcSEcCtD
Oxybutynin—Cough—Epirubicin—liver cancer	0.000567	0.00148	CcSEcCtD
Oxybutynin—Vision blurred—Doxorubicin—liver cancer	0.000567	0.00148	CcSEcCtD
Oxybutynin—Convulsion—Epirubicin—liver cancer	0.000563	0.00147	CcSEcCtD
Oxybutynin—Hypertension—Epirubicin—liver cancer	0.000561	0.00147	CcSEcCtD
Oxybutynin—Ill-defined disorder—Doxorubicin—liver cancer	0.000558	0.00146	CcSEcCtD
Oxybutynin—Arthralgia—Epirubicin—liver cancer	0.000554	0.00145	CcSEcCtD
Oxybutynin—Chest pain—Epirubicin—liver cancer	0.000554	0.00145	CcSEcCtD
Oxybutynin—Agitation—Doxorubicin—liver cancer	0.000553	0.00144	CcSEcCtD
Oxybutynin—Anxiety—Epirubicin—liver cancer	0.000552	0.00144	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00055	0.00144	CcSEcCtD
Oxybutynin—Discomfort—Epirubicin—liver cancer	0.000547	0.00143	CcSEcCtD
Oxybutynin—Malaise—Doxorubicin—liver cancer	0.000542	0.00142	CcSEcCtD
Oxybutynin—Dry mouth—Epirubicin—liver cancer	0.000541	0.00141	CcSEcCtD
Oxybutynin—Syncope—Doxorubicin—liver cancer	0.000539	0.00141	CcSEcCtD
Oxybutynin—Confusional state—Epirubicin—liver cancer	0.000535	0.0014	CcSEcCtD
Oxybutynin—Palpitations—Doxorubicin—liver cancer	0.000532	0.00139	CcSEcCtD
Oxybutynin—Oedema—Epirubicin—liver cancer	0.000531	0.00139	CcSEcCtD
Oxybutynin—Anaphylactic shock—Epirubicin—liver cancer	0.000531	0.00139	CcSEcCtD
Oxybutynin—Loss of consciousness—Doxorubicin—liver cancer	0.000529	0.00138	CcSEcCtD
Oxybutynin—Infection—Epirubicin—liver cancer	0.000527	0.00138	CcSEcCtD
Oxybutynin—Cough—Doxorubicin—liver cancer	0.000525	0.00137	CcSEcCtD
Oxybutynin—Shock—Epirubicin—liver cancer	0.000522	0.00136	CcSEcCtD
Oxybutynin—Convulsion—Doxorubicin—liver cancer	0.000521	0.00136	CcSEcCtD
Oxybutynin—Nervous system disorder—Epirubicin—liver cancer	0.00052	0.00136	CcSEcCtD
Oxybutynin—Hypertension—Doxorubicin—liver cancer	0.000519	0.00136	CcSEcCtD
Oxybutynin—Tachycardia—Epirubicin—liver cancer	0.000518	0.00135	CcSEcCtD
Oxybutynin—Skin disorder—Epirubicin—liver cancer	0.000515	0.00135	CcSEcCtD
Oxybutynin—Chest pain—Doxorubicin—liver cancer	0.000512	0.00134	CcSEcCtD
Oxybutynin—Arthralgia—Doxorubicin—liver cancer	0.000512	0.00134	CcSEcCtD
Oxybutynin—Anxiety—Doxorubicin—liver cancer	0.00051	0.00133	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000509	0.00133	CcSEcCtD
Oxybutynin—Discomfort—Doxorubicin—liver cancer	0.000506	0.00132	CcSEcCtD
Oxybutynin—Anorexia—Epirubicin—liver cancer	0.000506	0.00132	CcSEcCtD
Oxybutynin—Dry mouth—Doxorubicin—liver cancer	0.000501	0.00131	CcSEcCtD
Oxybutynin—Hypotension—Epirubicin—liver cancer	0.000496	0.0013	CcSEcCtD
Oxybutynin—Confusional state—Doxorubicin—liver cancer	0.000495	0.00129	CcSEcCtD
Oxybutynin—Oedema—Doxorubicin—liver cancer	0.000491	0.00128	CcSEcCtD
Oxybutynin—Anaphylactic shock—Doxorubicin—liver cancer	0.000491	0.00128	CcSEcCtD
Oxybutynin—Infection—Doxorubicin—liver cancer	0.000488	0.00127	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000483	0.00126	CcSEcCtD
Oxybutynin—Shock—Doxorubicin—liver cancer	0.000483	0.00126	CcSEcCtD
Oxybutynin—Nervous system disorder—Doxorubicin—liver cancer	0.000481	0.00126	CcSEcCtD
Oxybutynin—Insomnia—Epirubicin—liver cancer	0.00048	0.00125	CcSEcCtD
Oxybutynin—Tachycardia—Doxorubicin—liver cancer	0.000479	0.00125	CcSEcCtD
Oxybutynin—Skin disorder—Doxorubicin—liver cancer	0.000477	0.00125	CcSEcCtD
Oxybutynin—Paraesthesia—Epirubicin—liver cancer	0.000476	0.00124	CcSEcCtD
Oxybutynin—Somnolence—Epirubicin—liver cancer	0.000472	0.00123	CcSEcCtD
Oxybutynin—Anorexia—Doxorubicin—liver cancer	0.000468	0.00122	CcSEcCtD
Oxybutynin—Dyspepsia—Epirubicin—liver cancer	0.000467	0.00122	CcSEcCtD
Oxybutynin—Decreased appetite—Epirubicin—liver cancer	0.000461	0.00121	CcSEcCtD
Oxybutynin—Hypotension—Doxorubicin—liver cancer	0.000459	0.0012	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Epirubicin—liver cancer	0.000458	0.0012	CcSEcCtD
Oxybutynin—Fatigue—Epirubicin—liver cancer	0.000457	0.0012	CcSEcCtD
Oxybutynin—Constipation—Epirubicin—liver cancer	0.000454	0.00119	CcSEcCtD
Oxybutynin—Pain—Epirubicin—liver cancer	0.000454	0.00119	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000447	0.00117	CcSEcCtD
Oxybutynin—Insomnia—Doxorubicin—liver cancer	0.000444	0.00116	CcSEcCtD
Oxybutynin—Paraesthesia—Doxorubicin—liver cancer	0.000441	0.00115	CcSEcCtD
Oxybutynin—Feeling abnormal—Epirubicin—liver cancer	0.000437	0.00114	CcSEcCtD
Oxybutynin—Somnolence—Doxorubicin—liver cancer	0.000436	0.00114	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Epirubicin—liver cancer	0.000434	0.00113	CcSEcCtD
Oxybutynin—Dyspepsia—Doxorubicin—liver cancer	0.000432	0.00113	CcSEcCtD
Oxybutynin—Decreased appetite—Doxorubicin—liver cancer	0.000427	0.00112	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000424	0.00111	CcSEcCtD
Oxybutynin—Fatigue—Doxorubicin—liver cancer	0.000423	0.00111	CcSEcCtD
Oxybutynin—Urticaria—Epirubicin—liver cancer	0.000422	0.0011	CcSEcCtD
Oxybutynin—Pain—Doxorubicin—liver cancer	0.00042	0.0011	CcSEcCtD
Oxybutynin—Constipation—Doxorubicin—liver cancer	0.00042	0.0011	CcSEcCtD
Oxybutynin—Abdominal pain—Epirubicin—liver cancer	0.000419	0.0011	CcSEcCtD
Oxybutynin—Feeling abnormal—Doxorubicin—liver cancer	0.000405	0.00106	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Doxorubicin—liver cancer	0.000401	0.00105	CcSEcCtD
Oxybutynin—Hypersensitivity—Epirubicin—liver cancer	0.000391	0.00102	CcSEcCtD
Oxybutynin—Urticaria—Doxorubicin—liver cancer	0.00039	0.00102	CcSEcCtD
Oxybutynin—Abdominal pain—Doxorubicin—liver cancer	0.000388	0.00101	CcSEcCtD
Oxybutynin—Asthenia—Epirubicin—liver cancer	0.000381	0.000995	CcSEcCtD
Oxybutynin—Pruritus—Epirubicin—liver cancer	0.000375	0.000981	CcSEcCtD
Oxybutynin—Diarrhoea—Epirubicin—liver cancer	0.000363	0.000949	CcSEcCtD
Oxybutynin—Hypersensitivity—Doxorubicin—liver cancer	0.000362	0.000945	CcSEcCtD
Oxybutynin—Asthenia—Doxorubicin—liver cancer	0.000352	0.00092	CcSEcCtD
Oxybutynin—Dizziness—Epirubicin—liver cancer	0.000351	0.000917	CcSEcCtD
Oxybutynin—Pruritus—Doxorubicin—liver cancer	0.000347	0.000908	CcSEcCtD
Oxybutynin—Vomiting—Epirubicin—liver cancer	0.000337	0.000881	CcSEcCtD
Oxybutynin—Diarrhoea—Doxorubicin—liver cancer	0.000336	0.000878	CcSEcCtD
Oxybutynin—Rash—Epirubicin—liver cancer	0.000335	0.000874	CcSEcCtD
Oxybutynin—Dermatitis—Epirubicin—liver cancer	0.000334	0.000873	CcSEcCtD
Oxybutynin—Headache—Epirubicin—liver cancer	0.000332	0.000868	CcSEcCtD
Oxybutynin—Dizziness—Doxorubicin—liver cancer	0.000325	0.000848	CcSEcCtD
Oxybutynin—Nausea—Epirubicin—liver cancer	0.000315	0.000823	CcSEcCtD
Oxybutynin—Vomiting—Doxorubicin—liver cancer	0.000312	0.000816	CcSEcCtD
Oxybutynin—Rash—Doxorubicin—liver cancer	0.00031	0.000809	CcSEcCtD
Oxybutynin—Dermatitis—Doxorubicin—liver cancer	0.000309	0.000808	CcSEcCtD
Oxybutynin—Headache—Doxorubicin—liver cancer	0.000308	0.000804	CcSEcCtD
Oxybutynin—Nausea—Doxorubicin—liver cancer	0.000292	0.000762	CcSEcCtD
Oxybutynin—CYP2C8—Metabolism—GGT1—liver cancer	3.06e-05	0.000249	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—PIK3CB—liver cancer	3.04e-05	0.000248	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IGF2—liver cancer	3.04e-05	0.000248	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PPARA—liver cancer	3e-05	0.000245	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PSMA4—liver cancer	2.99e-05	0.000244	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PSMD10—liver cancer	2.99e-05	0.000244	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTA4—liver cancer	2.95e-05	0.000241	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GSTM1—liver cancer	2.91e-05	0.000238	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GOT2—liver cancer	2.91e-05	0.000237	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—BRAF—liver cancer	2.88e-05	0.000235	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTA2—liver cancer	2.87e-05	0.000235	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CSF2—liver cancer	2.87e-05	0.000234	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—RAF1—liver cancer	2.87e-05	0.000234	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CSF2—liver cancer	2.86e-05	0.000234	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—RAF1—liver cancer	2.86e-05	0.000233	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CSF2—liver cancer	2.84e-05	0.000231	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—H2AFX—liver cancer	2.83e-05	0.000231	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—IL2—liver cancer	2.83e-05	0.000231	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—RAF1—liver cancer	2.83e-05	0.000231	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—H2AFX—liver cancer	2.82e-05	0.00023	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—IL2—liver cancer	2.82e-05	0.00023	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—PIK3CB—liver cancer	2.8e-05	0.000228	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—H2AFX—liver cancer	2.8e-05	0.000228	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—IL2—liver cancer	2.79e-05	0.000228	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—PIK3CB—liver cancer	2.79e-05	0.000228	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTA1—liver cancer	2.77e-05	0.000226	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—PIK3CB—liver cancer	2.76e-05	0.000225	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CYP1A1—liver cancer	2.76e-05	0.000225	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GSTP1—liver cancer	2.75e-05	0.000224	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—NAT2—liver cancer	2.74e-05	0.000224	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CYP2E1—liver cancer	2.73e-05	0.000223	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—HMOX1—liver cancer	2.71e-05	0.000221	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PIK3CD—liver cancer	2.69e-05	0.00022	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—PIK3CA—liver cancer	2.67e-05	0.000218	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—SERPINE1—liver cancer	2.67e-05	0.000217	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—KRAS—liver cancer	2.64e-05	0.000215	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALDOB—liver cancer	2.63e-05	0.000214	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—MTHFR—liver cancer	2.57e-05	0.00021	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CG—liver cancer	2.57e-05	0.00021	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—IL2—liver cancer	2.57e-05	0.00021	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—IL2—liver cancer	2.56e-05	0.000209	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TERT—liver cancer	2.56e-05	0.000209	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CYCS—liver cancer	2.56e-05	0.000209	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TERT—liver cancer	2.55e-05	0.000208	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—IL2—liver cancer	2.54e-05	0.000207	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TERT—liver cancer	2.53e-05	0.000206	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PPARA—liver cancer	2.53e-05	0.000206	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GSTM1—liver cancer	2.52e-05	0.000206	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GOT1—liver cancer	2.51e-05	0.000205	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GGT1—liver cancer	2.51e-05	0.000205	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CRABP1—liver cancer	2.51e-05	0.000205	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PPARG—liver cancer	2.48e-05	0.000203	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—PIK3CA—liver cancer	2.42e-05	0.000198	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—RAF1—liver cancer	2.41e-05	0.000196	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CYP1A1—liver cancer	2.39e-05	0.000195	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MTOR—liver cancer	2.35e-05	0.000192	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PIK3CB—liver cancer	2.35e-05	0.000192	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—KDR—liver cancer	2.34e-05	0.000191	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—KDR—liver cancer	2.34e-05	0.000191	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MAPK14—liver cancer	2.33e-05	0.00019	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MAPK14—liver cancer	2.32e-05	0.000189	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—KDR—liver cancer	2.31e-05	0.000189	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MAPK14—liver cancer	2.3e-05	0.000187	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ESR1—liver cancer	2.28e-05	0.000186	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ESR1—liver cancer	2.28e-05	0.000186	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CD—liver cancer	2.26e-05	0.000185	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—F2—liver cancer	2.26e-05	0.000184	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GSTP1—liver cancer	2.25e-05	0.000184	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ESR1—liver cancer	2.25e-05	0.000184	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—F2—liver cancer	2.25e-05	0.000183	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—HRAS—liver cancer	2.24e-05	0.000183	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—ALB—liver cancer	2.23e-05	0.000182	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—MTHFR—liver cancer	2.23e-05	0.000182	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—F2—liver cancer	2.23e-05	0.000182	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—HMOX1—liver cancer	2.22e-05	0.000181	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CDKN1B—liver cancer	2.2e-05	0.00018	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—HPGDS—liver cancer	2.19e-05	0.000179	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PPARA—liver cancer	2.19e-05	0.000178	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—AKT1—liver cancer	2.18e-05	0.000178	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CG—liver cancer	2.16e-05	0.000176	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CASP3—liver cancer	2.16e-05	0.000176	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—APC—liver cancer	2.16e-05	0.000176	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CG—liver cancer	2.16e-05	0.000176	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—IL2—liver cancer	2.16e-05	0.000176	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CG—liver cancer	2.15e-05	0.000175	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—APC—liver cancer	2.15e-05	0.000175	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—IL6—liver cancer	2.15e-05	0.000175	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—APC—liver cancer	2.13e-05	0.000174	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CG—liver cancer	2.13e-05	0.000174	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CCND1—liver cancer	2.1e-05	0.000172	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—JUN—liver cancer	2.1e-05	0.000171	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PPARG—liver cancer	2.09e-05	0.00017	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CTNNB1—liver cancer	2.08e-05	0.00017	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GSTM1—liver cancer	2.07e-05	0.000169	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MMP9—liver cancer	2.04e-05	0.000167	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CDKN1A—liver cancer	2.03e-05	0.000166	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—BRAF—liver cancer	2.03e-05	0.000165	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—BRAF—liver cancer	2.02e-05	0.000165	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—BRAF—liver cancer	2e-05	0.000163	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MAPK8—liver cancer	1.99e-05	0.000162	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—AKT1—liver cancer	1.98e-05	0.000162	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CB—liver cancer	1.97e-05	0.000161	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.97e-05	0.00016	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CYP1A1—liver cancer	1.96e-05	0.00016	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PSMA4—liver cancer	1.95e-05	0.000159	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PSMD10—liver cancer	1.95e-05	0.000159	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CD—liver cancer	1.9e-05	0.000155	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GOT2—liver cancer	1.9e-05	0.000155	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CD—liver cancer	1.9e-05	0.000155	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CD—liver cancer	1.89e-05	0.000154	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—PIK3CA—liver cancer	1.88e-05	0.000153	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ALB—liver cancer	1.88e-05	0.000153	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—SERPINE1—liver cancer	1.88e-05	0.000153	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CG—liver cancer	1.87e-05	0.000153	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—PIK3CA—liver cancer	1.87e-05	0.000153	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CD—liver cancer	1.87e-05	0.000153	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—SERPINE1—liver cancer	1.87e-05	0.000153	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—KRAS—liver cancer	1.86e-05	0.000152	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—PIK3CA—liver cancer	1.86e-05	0.000151	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—SERPINE1—liver cancer	1.85e-05	0.000151	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—KRAS—liver cancer	1.85e-05	0.000151	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—KRAS—liver cancer	1.83e-05	0.00015	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—VEGFA—liver cancer	1.83e-05	0.00015	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—MTHFR—liver cancer	1.83e-05	0.000149	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—STAT3—liver cancer	1.82e-05	0.000148	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PPARG—liver cancer	1.81e-05	0.000148	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PPARA—liver cancer	1.8e-05	0.000147	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP2E1—liver cancer	1.79e-05	0.000146	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—PIK3CA—liver cancer	1.71e-05	0.000139	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—PIK3CA—liver cancer	1.7e-05	0.000139	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—RAF1—liver cancer	1.69e-05	0.000138	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—RAF1—liver cancer	1.69e-05	0.000138	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MYC—liver cancer	1.69e-05	0.000138	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—PIK3CA—liver cancer	1.68e-05	0.000137	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TGFB1—liver cancer	1.68e-05	0.000137	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYCS—liver cancer	1.67e-05	0.000136	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—RAF1—liver cancer	1.67e-05	0.000136	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CB—liver cancer	1.66e-05	0.000135	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CB—liver cancer	1.65e-05	0.000135	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MTOR—liver cancer	1.65e-05	0.000135	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CB—liver cancer	1.65e-05	0.000134	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MTOR—liver cancer	1.65e-05	0.000134	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CD—liver cancer	1.65e-05	0.000134	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GOT1—liver cancer	1.64e-05	0.000134	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GGT1—liver cancer	1.64e-05	0.000134	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MTOR—liver cancer	1.63e-05	0.000133	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CB—liver cancer	1.63e-05	0.000133	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ALB—liver cancer	1.63e-05	0.000133	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—HRAS—liver cancer	1.58e-05	0.000129	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—HRAS—liver cancer	1.57e-05	0.000128	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—HRAS—liver cancer	1.56e-05	0.000127	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—KRAS—liver cancer	1.56e-05	0.000127	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CDKN1B—liver cancer	1.55e-05	0.000127	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CDKN1B—liver cancer	1.55e-05	0.000126	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CG—liver cancer	1.54e-05	0.000125	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—AKT1—liver cancer	1.54e-05	0.000125	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CDKN1B—liver cancer	1.53e-05	0.000125	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—AKT1—liver cancer	1.53e-05	0.000125	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CASP3—liver cancer	1.52e-05	0.000124	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IL2—liver cancer	1.52e-05	0.000124	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CASP3—liver cancer	1.52e-05	0.000124	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—AKT1—liver cancer	1.52e-05	0.000124	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IL2—liver cancer	1.51e-05	0.000123	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—IL6—liver cancer	1.51e-05	0.000123	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—IL6—liver cancer	1.51e-05	0.000123	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CASP3—liver cancer	1.5e-05	0.000122	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IL2—liver cancer	1.5e-05	0.000122	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—IL6—liver cancer	1.49e-05	0.000122	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PPARG—liver cancer	1.48e-05	0.000121	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CCND1—liver cancer	1.48e-05	0.000121	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—JUN—liver cancer	1.48e-05	0.000121	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CCND1—liver cancer	1.48e-05	0.00012	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTP1—liver cancer	1.47e-05	0.00012	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—JUN—liver cancer	1.47e-05	0.00012	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CTNNB1—liver cancer	1.47e-05	0.00012	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CTNNB1—liver cancer	1.46e-05	0.000119	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CCND1—liver cancer	1.46e-05	0.000119	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—JUN—liver cancer	1.46e-05	0.000119	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—HMOX1—liver cancer	1.45e-05	0.000119	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CTNNB1—liver cancer	1.45e-05	0.000118	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MMP9—liver cancer	1.44e-05	0.000117	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CB—liver cancer	1.44e-05	0.000117	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MMP9—liver cancer	1.43e-05	0.000117	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CDKN1A—liver cancer	1.43e-05	0.000117	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PIK3CA—liver cancer	1.43e-05	0.000117	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CDKN1A—liver cancer	1.43e-05	0.000116	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MMP9—liver cancer	1.42e-05	0.000116	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CDKN1A—liver cancer	1.41e-05	0.000115	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MAPK8—liver cancer	1.4e-05	0.000114	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—AKT1—liver cancer	1.39e-05	0.000114	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MAPK8—liver cancer	1.39e-05	0.000114	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—AKT1—liver cancer	1.39e-05	0.000113	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TP53—liver cancer	1.39e-05	0.000113	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MAPK8—liver cancer	1.38e-05	0.000113	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—AKT1—liver cancer	1.38e-05	0.000112	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTM1—liver cancer	1.35e-05	0.00011	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CD—liver cancer	1.35e-05	0.00011	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ALB—liver cancer	1.34e-05	0.000109	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—HRAS—liver cancer	1.32e-05	0.000108	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—VEGFA—liver cancer	1.29e-05	0.000105	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—VEGFA—liver cancer	1.29e-05	0.000105	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP1A1—liver cancer	1.28e-05	0.000105	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—STAT3—liver cancer	1.28e-05	0.000104	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—VEGFA—liver cancer	1.27e-05	0.000104	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—STAT3—liver cancer	1.27e-05	0.000104	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—IL6—liver cancer	1.27e-05	0.000103	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—STAT3—liver cancer	1.26e-05	0.000103	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CA—liver cancer	1.2e-05	9.8e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—MTHFR—liver cancer	1.2e-05	9.77e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MYC—liver cancer	1.19e-05	9.69e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TGFB1—liver cancer	1.18e-05	9.66e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MYC—liver cancer	1.18e-05	9.66e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TGFB1—liver cancer	1.18e-05	9.63e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CB—liver cancer	1.18e-05	9.62e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PPARA—liver cancer	1.17e-05	9.58e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MYC—liver cancer	1.17e-05	9.56e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—AKT1—liver cancer	1.17e-05	9.54e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TGFB1—liver cancer	1.17e-05	9.54e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—KRAS—liver cancer	1.1e-05	8.95e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—KRAS—liver cancer	1.09e-05	8.92e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—KRAS—liver cancer	1.08e-05	8.84e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CA—liver cancer	1.01e-05	8.24e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CA—liver cancer	1.01e-05	8.22e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CG—liver cancer	1.01e-05	8.2e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CA—liver cancer	1e-05	8.2e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CA—liver cancer	9.95e-06	8.12e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—AKT1—liver cancer	9.82e-06	8.01e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TP53—liver cancer	9.75e-06	7.96e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TP53—liver cancer	9.72e-06	7.93e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PPARG—liver cancer	9.71e-06	7.92e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TP53—liver cancer	9.63e-06	7.85e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HRAS—liver cancer	9.33e-06	7.61e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HRAS—liver cancer	9.3e-06	7.58e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HRAS—liver cancer	9.21e-06	7.51e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IL6—liver cancer	8.93e-06	7.28e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IL6—liver cancer	8.9e-06	7.26e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CD—liver cancer	8.84e-06	7.21e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IL6—liver cancer	8.81e-06	7.19e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CA—liver cancer	8.75e-06	7.14e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALB—liver cancer	8.73e-06	7.12e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—AKT1—liver cancer	8.26e-06	6.73e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AKT1—liver cancer	8.24e-06	6.72e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AKT1—liver cancer	8.21e-06	6.7e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AKT1—liver cancer	8.13e-06	6.63e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CB—liver cancer	7.71e-06	6.29e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CA—liver cancer	7.19e-06	5.86e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—AKT1—liver cancer	7.15e-06	5.83e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—AKT1—liver cancer	5.87e-06	4.79e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CA—liver cancer	4.7e-06	3.83e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—AKT1—liver cancer	3.84e-06	3.13e-05	CbGpPWpGaD
